Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9643616 | Journal of the American Academy of Child & Adolescent Psychiatry | 2005 | 10 Pages |
Abstract
In pediatric patients with ADHD and comorbid symptoms of depression or anxiety, atomoxetine monotherapy appears to be effective for treating ADHD. Anxiety and depressive symptoms also improved, but the absence of a placebo-only arm does not allow us to conclude that these effects are specifically the result of treatment with atomoxetine. Combined atomoxetine/fluoxetine therapy was well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Christopher J. M.D., Jeffrey H. M.D., L. Eugene M.D., David M.D., Graham J. M.D., Humberto M.D., Elias H. M.D., Karen Dineen M.D., Ph.D., Haitao Ph.D., David M.D., Joseph M.D.,